Can I read Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes on EtoBox?

Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes by Stephen A. Chan; Kathryn M. Van Abel; Jean E. Lewis; David M. Routman; Joaquin J. Garcia; Emily E. Karp; Daniel L. Price; Jeffrey R. Janus; Jan L. Kasperbauer; Eric J. Moore is a Medicine article available to read on EtoBox.

What is Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes about?

## Background: Parotid gland mucoepidermoid carcinoma (mec) has published five-year cancer-specific survival (css) rates of 77%-97%, with variance related to grade. ## Methods: Patients receiving primary surgery for parotid gland mec from 1995 to 2014 at a tertiary medical center underwent clinical review, histopathologic review, and cytogenetic analysis. survival outcomes were evaluated. ## Results: Among 58 patients, t/n/m classification was as follows: t1 in 35 patients, t2 in 14, t4a in 9, n0 in 53, n1 in 2, n2b in 3. histologic grade was low in 27, intermediate in 17, and high in 12 patients with 98% maml2 positivity. all patients underwent parotidectomy, and seven patients received adjuvant radiation therapy. css was 100% at 5 years and 94.1% at 10 and 15 years. two patients experienced locoregional recurrence. ## Conclusions: Treatment with adequate surgical resection and adjuvant radiation therapy for high-grade or advanced-stage tumors yields excellent survival, independent of clinical stage or pathologic grade.

Who reads Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes?

Author

Stephen A. Chan; Kathryn M. Van Abel; Jean E. Lewis; David M. Routman; Joaquin J. Garcia; Emily E. Karp; Daniel L. Price; Jeffrey R. Janus; Jan L. Kasperbauer; Eric J. Moore

Publisher

Wiley

Published

2021

Language

EN

Field

Medicine (Health Sciences)